Categories: News

Neutra Thanks Seed Investor, Readies for Strong Second-Half Growth

KATY, TX / ACCESSWIRE / June 22, 2022 / Despite a rough national economy, Neutra Corp. (OTC PINK:NTRR) believes its best days are ahead and is preparing for a strong final six months of 2022. The company has several reasons for optimism, including completion of a new manufacturing facility through the year of the pandemic, a solid portfolio of revenue-producing CBD brands and alternative cannabinoid products, little debt and a focused plan for continued future growth. One thing Neutra is not planning for is a reverse split.

“Let me clear, Neutra has no intention for a reverse split in the foreseeable future,” Neutra CEO Sydney Jim said. “We are in a strong position today and there’s just no reason for one. Our last debt holder has not converted since 2015. We’re in a good spot because we’ve executed our growth plan and thanks to strong support from Power Up Funding. They’ve been behind us at every step and we appreciate that.”

Jim added that Power Up has completed all of their Series G convertible preferred shares, meaning there will be no more conversions or dilution.

Neutra can boast of several successes so far this year. These include the launching of a new advertising and sales campaign backed by new e-commerce sites for the VIVIS and Deity Wellness brands. Deity also rolled out fresh new designs on packaging for its 10-pack of 25-mg Delta-8 gummies and vape cartridges. The designs better differentiate Deity from the competition.

On the product side, Deity gets ready to launch a new product offering that was due to be launched in April. Fortunately, all the kinks are over with and the new product offering launches next week.

While some economists fear the U.S. may soon slide into a recession, the market for CBD and alternative cannabinoids remains strong. One blogger believes the total Hemp based cannabinoid market will approach $8 billion in 2022 even with recent inflation.

About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food, and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.NeutraInc.com.

NOTICE REGARDING FORWARD-LOOKING STATEMENTS
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words ‘believes,’ ‘expects,’ ‘anticipate’ or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com

SOURCE: Neutra Corp

View source version on accesswire.com:
https://www.accesswire.com/706137/Neutra-Thanks-Seed-Investor-Readies-for-Strong-Second-Half-Growth

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

20 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

2 days ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

2 days ago